To unravel the molecular mechanism underlying NeuroD1 regulation of GPX4, we examined the effect of inhibiting de novo transcription and protein synthesis in NeuroD1-knocked down HCC-LM3 cells. The gene discussed is GPX4; the disease is hepatocellular carcinoma.